← back to search

Hervé Dombret

Université Paris Cité · FR
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, and Eosinophilic Disorders and Syndromes.
h-index
15
citations
3,582
works
21
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
New England Journal of Medicine 2017cited by 2,064position: middledoi
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia
Haematologica 2016cited by 221position: middledoi
Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification
Haematologica 2013cited by 41position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nicola Gökbuget · Frankfurt Cancer Institute2 papers (2016–2017)Adele K. Fielding · New York Blood Center2 papers (2016–2017)Josep‐María Ribera · Josep Carreras Leukaemia Research Institute2 papers (2016–2017)Wolfgang Hiddemann · Deutsche Forschungsgemeinschaft2 papers (2013–2017)Renato Bassan · Fondazione Gimema Onlus2 papers (2016–2017)— · 1 papers (2013–2013)— · 1 papers (2016–2016)Meir Wetzler · University of Colorado Denver1 papers (2013–2013)Sebastian Giebel · Medical University of Warsaw1 papers (2016–2016)Michael Doubek · Comenius University Bratislava1 papers (2016–2016)Martha Wadleigh · University of Alabama at Birmingham1 papers (2016–2016)Jessica Kohlschmidt · The Ohio State University1 papers (2013–2013)Alessandro Rambaldi · Astellas Pharma (United States)1 papers (2017–2017)Julia Stieglmaier · Thomas Jefferson University1 papers (2016–2016)Guido Marcucci · City of Hope1 papers (2013–2013)Clara D. Bloomfield · The Ohio State University1 papers (2013–2013)D. Hoelzer · Oak Ridge National Laboratory1 papers (2016–2016)Jacob M. Rowe · Technion – Israel Institute of Technology1 papers (2016–2016)Michael A. Kelsh · Amgen (United States)1 papers (2016–2016)Dirk Nagorsen · C4 Therapeutics (United States)1 papers (2017–2017)